Syntezza Bioscience

Molecular Biology Products and Services

Health Tech & Life Sciences
Active
Mature Jerusalem Founded 2004
Total raised
Stage
Mature
Founded
2004
Headcount
16
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

Syntezza Bioscience is a provider and exclusive distributor of molecular biology products and services. Its products include custom DNA and RNA oligos, genes, enzymes, peptides, research kits, and reagents, and are designated for NGS and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) screens. The company offers both Sanger and NGS sequencing services. Syntezza Bioscience also leads contract research projects in the diagnostics field.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Syntezza Bioscience's primary business focus?
Syntezza Bioscience is a provider and exclusive distributor of molecular biology products and services, including custom DNA and RNA oligos, genes, enzymes, peptides, research kits, and reagents for NGS and CRISPR screens. The company also offers Sanger and NGS sequencing services and leads contract research projects in diagnostics.
When was Syntezza Bioscience founded?
Syntezza Bioscience was founded in January 2004.
Where is Syntezza Bioscience headquartered?
Syntezza Bioscience is headquartered in Jerusalem, Israel, at Hartom Street 17.
What markets does Syntezza Bioscience operate in?
Syntezza Bioscience operates in the geographic markets of Israel and the United States.
What is the employee count for Syntezza Bioscience?
Syntezza Bioscience has an employee count ranging from 11 to 50, with an exact count of 16 employees.
What is Syntezza Bioscience's primary sector classification?
Syntezza Bioscience's primary sector classification is Health Tech & Life Sciences.
Has Syntezza Bioscience raised any external funding?
According to startupim data, Syntezza Bioscience has not raised any external funding, with a total raised amount of $0 USD.
What specific product does Syntezza Bioscience offer?
Syntezza Bioscience offers the product shERWOOD-UltramiR shRNA.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

molecular-biologytestinggenetic-engineeringchemicalslaboratories